Supplemental Figure 1 from Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma
Authors:
- Steven G. DuBoisSDSteven G. DuBois
- Yael P. MosseYMYael P. Mosse
- Elizabeth FoxEFElizabeth Fox
- Rachel A. KudgusRKRachel A. Kudgus
- Joel M. ReidJRJoel M. Reid
- Renee McGovernRMRenee McGovern
- Susan GroshenSGSusan Groshen
- Rochelle BagatellRBRochelle Bagatell
- John M. MarisJMJohn M. Maris
- Clare J. TwistCTClare J. Twist
- Kelly GoldsmithKGKelly Goldsmith
- M. Meaghan GrangerMGM. Meaghan Granger
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)